Australia’s Paradigm Biopharmaceuticals says phase 2 trial in osteoarthritis shows signs of disease modification at 6-month follow-up
April 11, 2023 05:00 ET
|
Paradigm Biopharmaceuticals
MELBOURNE, Australia, April 11, 2023 (GLOBE NEWSWIRE) -- Australia’s Paradigm Biopharmaceuticals Ltd (ASX:PAR) says analysis of six-month trial data shows injectable pentosan polysulfate sodium...
Heat Therapy Market Is Expected to Generate $2.4 Billion by 2031: Allied Market Research
April 06, 2023 11:34 ET
|
Allied Market Research
Portland, OR, April 06, 2023 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global heat therapy market garnered $1.4 billion in 2021, and is estimated to...
PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE IVAPM PAIN MANAGEMENT FORUM IN ATLANTA, GEORGIA
March 27, 2023 08:00 ET
|
PetVivo Holdings, Inc.
MINNEAPOLIS, March 27, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative...
Clinical Study Results Involving Spryng, a PetVivo Holdings, Inc. Product, Presented at the Veterinary Orthopedic Society Annual Conference in Big Sky, Montana
March 17, 2023 10:00 ET
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, US, March 17, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) (the “Company” or “PetVivo") an emerging biomedical device company focused on the...
PetVivo Holdings, Inc. to Exhibit and Dr. Erik Kleeman of Ethos Veterinary Health to Present Canine Study Results at the Veterinary Orthopedic Society Annual Conference
March 10, 2023 08:00 ET
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, US, March 10, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) (the “Company” or “PetVivo") an emerging biomedical device company focused on the...
The Arthritis Therapeutics Market Is Estimated To Grow 1.5x During By 2027: Fact.MR Analysis
March 06, 2023 14:00 ET
|
FACT.MR
Rockville , March 06, 2023 (GLOBE NEWSWIRE) -- The global arthritis therapeutics market would expand 1.5 times from 2020 to 2027. Patients in Europe and North America would push demand for...
PETVIVO HOLDINGS, INC. TO EXHIBIT AT THE WESTERN VETERINARY CONFERENCE IN LAS VEGAS, NEVADA
February 13, 2023 08:00 ET
|
PetVivo Holdings, Inc.
MINNEAPOLIS, Feb. 13, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo") an emerging biomedical device company focused on the commercialization of innovative...
PetVivo Reports Third Quarter of Fiscal 2023 Financial Results
February 09, 2023 16:00 ET
|
PetVivo Holdings, Inc.
Conference call begins at 4:00 p.m. Central time today EDINA, MN , Feb. 09, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (Nasdaq: PETV and PETVW), an emerging biomedical device company...
PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE THIRD QUARTER ENDED DECEMBER 31, 2022
February 02, 2023 08:00 ET
|
PetVivo Holdings, Inc.
MINNEAPOLIS, MN, US, Feb. 02, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV and PETVW), an emerging biomedical device company focused on the commercialization of innovative medical...
[Latest] Global Hyaluronic Acid Market Size/Share Worth USD 2.6 Billion by 2030 at an 8% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
February 01, 2023 14:30 ET
|
Custom Market Insights
Sandy, Utah, USA, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Hyaluronic Acid Market Size, Trends and Insights By Grade (Food, Cosmetic,...